Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

The use of SGLT2 inhibitors vs GLP-1 receptor agonists was linked to a reduced risk for ULT and colchicine initiation among ...

Good news for people with diabetes who can enjoy better kidney health as well as ward off gout, thanks to a pioneering ...

New Phase III data for AstraZeneca's gout drug lesinurad have backed its efficacy and seem to address earlier concerns about its safety. Last year, AZ reported the results of the Phase III LIGHT ...

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada ...